Percheron Therapeutics (PERCF) Q2 2024 Earnings Report
PERCF Q2 2024 EPS Results
- Actual EPS
- $0.00
- Consensus EPS
- -$0.01
- Beat/Miss
- Beat by +$0.00
- One Year Ago EPS
- -$0.01
PERCF Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 02/28/2024
- Time
- Before Open
- Conference Call
- Wednesday, February 28, 2024
PERCF Upcoming Earnings
Percheron Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
PERCF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2027 (Q2) | ―- | 0 | ― | ― |
| Aug 19, 2026 | 2026 (Q4) | ―-0.00 | 0 | 83.33% (+0.00) | |
| Feb 26, 2026 | 2026 (Q2) | ―-0.00 | -0.01 | 66.67% (+0.00) | |
| Aug 28, 2025 | 2025 (Q4) | ―-0.00 | -0.01 | 25.00% (+0.00) | |
| Feb 19, 2025 | 2025 (Q2) | -0.01-0.01 | 0 | -50.00% (-0.00) | |
| Aug 29, 2024 | 2024 (Q4) | -0.00-0.01 | -0.01 | 11.11% (+0.00) | |
| Feb 28, 2024 | 2024 (Q2) | -0.01-0.00 | -0.01 | 25.00% (+0.00) | |
| Aug 25, 2023 | 2023 (Q4) | -0.01-0.01 | 0 | -125.00% (-0.00) | |
| Feb 22, 2023 | 2023 (Q2) | -0.01-0.01 | 0 | -60.00% (-0.00) | |
| Aug 31, 2022 | 2022 (Q4) | -0.01-0.00 | -0.01 | 63.64% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed